Elanco Announces Product Launches and Regulatory Approvals in Animal Health
Elanco has launched Befrena™ (tirnovetmab), a new anti-IL-31 monoclonal antibody for canine dermatology, and announced several regulatory updates including an improved label for Zenrelia™.